Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Epidermolysis Bullosa(EB) is an inherited bullous disease. Tetracycline is believed to have
anti inflammatory properties. 20 patients with EB older than 13 years will be treated for 4
months with tetracycline or placebo. After one month of wash out they will be treated for
additional 4 m with placebo or tetracycline. The patients will be examined each month to
estimate bulla formation,rate of healing .